MediFind found 133 doctor with experience in Neuroendocrine Tumor near Detroit, MI. Of these, 109 are Experienced, 19 are Advanced and 5 are Distinguished.
Henry Ford Health System
David Kwon is a General Surgeon and a Surgical Oncologist in Detroit, Michigan. Dr. Kwon is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pancreatic Cancer, Familial Pancreatic Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreatectomy, and Small Bowel Resection. Dr. Kwon is currently accepting new patients.
Henry Ford Health System
Ira Wollner is an Oncologist in Detroit, Michigan. Dr. Wollner is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Gallbladder Adenocarcinoma, Familial Colorectal Cancer, Fibrolamellar Carcinoma, Cholangiocarcinoma (Bile Duct Cancer), and Bone Marrow Aspiration. Dr. Wollner is currently accepting new patients.
Henry Ford Health System
Rupen Shah is a Surgical Oncologist and a General Surgeon in Detroit, Michigan. Dr. Shah is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Colorectal Cancer, Colorectal Cancer, Neuroendocrine Tumor, Small Bowel Resection, and Gallbladder Removal. Dr. Shah is currently accepting new patients.
Henry Ford Health System
Jack Rock is a Neurosurgery provider in Detroit, Michigan. Dr. Rock is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Meningioma, Pituitary Tumor, Prolactinoma, Balloon Sinuplasty, and Awake Craniotomy. Dr. Rock is currently accepting new patients.
Henry Ford Health System
Philip Kuriakose is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Kuriakose is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Primary Lymphoma of the Brain, Thrombocytopenia, Large-Cell Immunoblastic Lymphoma, Multiple Myeloma, and Bone Marrow Aspiration. Dr. Kuriakose is currently accepting new patients.
Henry Ford Health System
Marwan Abouljoud is a General Surgeon and a Transplant Surgeon in Detroit, Michigan. Dr. Abouljoud is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Hepatitis, Liver Failure, Familial Colorectal Cancer, Liver Transplant, and Kidney Transplant. Dr. Abouljoud is currently accepting new patients.
Steven Kalkanis is a Neurosurgery provider in Detroit, Michigan. Dr. Kalkanis is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Brain Tumor, Glioma, Gliomatosis Cerebri, and Metastatic Brain Tumor. Dr. Kalkanis is currently accepting new patients.
AP MI Heme & Onc Consultants Dr Musa
Faisal Musa is a Hematologist and an Oncologist in Dearborn, Michigan. Dr. Musa has been practicing medicine for over 20 years and is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Musa is currently accepting new patients.
University Physician Group
Eliza Beal is a General Surgeon and a Surgical Oncologist in Detroit, Michigan. Dr. Beal is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. Her top areas of expertise are Gallbladder Cancer, Cholangiocarcinoma (Bile Duct Cancer), Gallbladder Disease, Hepato-Pancreato-Biliary Surgery, and Hepatectomy. Dr. Beal is currently accepting new patients.
Henry Ford Health System
Shunji Nagai is a Transplant Surgeon and a General Surgeon in Detroit, Michigan. Dr. Nagai is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Liver Failure, Hepatitis, Neuroendocrine Tumor, Liver Transplant, and Kidney Transplant. Dr. Nagai is currently accepting new patients.
Karmanos Cancer Institute - Detroit Headquarters
Ammar Sukari is an Oncologist in Detroit, Michigan. Dr. Sukari has been practicing medicine for over 27 years and is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Head and Neck Squamous Cell Carcinoma (HNSCC), Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Laryngeal Cancer, and Gastrostomy. Dr. Sukari is currently accepting new patients.
Henry Ford Health System
Shirish Gadgeel is an Oncologist and a Hematologist in Detroit, Michigan. Dr. Gadgeel is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Squamous Cell Lung Carcinoma, EGFR Positive Lung Cancer, and Tissue Biopsy. Dr. Gadgeel is currently accepting new patients.
Henry Ford Health St. John Hospital
Wajahat Khan is an Oncologist in Grosse Pointe Woods, Michigan. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Pleuropulmonary Blastoma, Lung Cancer, Familial Colorectal Cancer, and Bone Marrow Aspiration. Dr. Khan is currently accepting new patients.
Henry Ford Health St. John Hospital
Adam Biedny is a Hematologist Oncology specialist and a Hematologist in Grosse Pointe Woods, Michigan. Dr. Biedny is rated as an Experienced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Astrocytoma, Gliosarcoma, Ependymoma, and Glioblastoma. Dr. Biedny is currently accepting new patients.
Corewell Health William Beaumont University Hospital Neurology - 3555 W 13 Mile
Jeffrey Jacob is a Neurosurgery provider in Royal Oak, Michigan. Dr. Jacob is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Acoustic Neuroma, Schwannoma, Subependymoma, Gamma Knife Radiosurgery, and Awake Craniotomy. Dr. Jacob is currently accepting new patients.
Corewell Health William Beaumont University Hospital Interventional Radiology Clinic
Jeremy Handel is a Radiologist and an Interventional Radiologist in Royal Oak, Michigan. Dr. Handel is rated as a Distinguished provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Pelvic Congestion Syndrome, Neuroendocrine Tumor, Visceromegaly, Liver Embolization, and Endoscopy. Dr. Handel is currently accepting new patients.
Donald Weaver is a General Surgeon in Detroit, Michigan. Dr. Weaver is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Familial Pancreatic Cancer, Neuroendocrine Tumor, Familial Colorectal Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Weaver is currently accepting new patients.
Barbara Ann Karmanos Cancer Institute
Jeffrey Critchfield is an Interventional Radiologist and a Radiologist in Detroit, Michigan. Dr. Critchfield is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Neuroendocrine Tumor, Lung Cancer, Laryngeal Cancer, Liver Embolization, and Gastrostomy. Dr. Critchfield is currently accepting new patients.
University Physician Group
Anthony Shields is a Hematologist Oncology specialist and a Hematologist in Detroit, Michigan. Dr. Shields is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Anal Cancer, and Pseudomyxoma Peritonei. Dr. Shields is currently accepting new patients.
University Physician Group
Mohammed Al Hallak is a Hematologist Oncology specialist and an Oncologist in Detroit, Michigan. Dr. Al Hallak is rated as an Advanced provider by MediFind in the treatment of Neuroendocrine Tumor. His top areas of expertise are Colorectal Cancer, Familial Colorectal Cancer, Gastrointestinal Stromal Tumor, and Familial Pancreatic Cancer. Dr. Al Hallak is currently accepting new patients.
Last Updated: 01/09/2026



